Extended Mortality Results for Ovarian Cancer Screening in the PLCO Trial with Median 15 Years Follow-up

BACKGROUND: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4 years of follow-up. The UKCTOCS screening trial failed to show a statistically significant mortality reduction in the prima...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gynecol Oncol
Hlavní autoři: Pinsky, Paul F., Yu, Kelly, Kramer, Barnett S., Black, Amanda, Buys, Saundra S., Partridge, Edward, Gohagan, John, Berg, Christine D., Prorok, Philip C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5077651/
https://ncbi.nlm.nih.gov/pubmed/27615399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.08.334
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky